Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
AUM Biosciences, a global clinical-stage biotech company, focused on discovering and developing novel targeted oncology therapies, has entered into a clinical trial collaboration and supply agreement with MSD, a tradename of Merck & Co., Inc., Rahway...
read more
Thursday, December 01, 2022
August Bioservices, a CDMO providing drug discovery, development and pharmaceutical manufacturing services, announced $65 million in Series B funding led by Oak HC/FT, who led the Series A in July 2020. This round includes participation from existing...
read more
August Bioservices,LLC, a contract development and manufacturing organization (CDMO) providing drug discovery, development, and pharmaceutical manufacturing services, closed a $23.6 million Series A extension, led by Polaris Partners, who joined ...
read more
The American Urogynecologic Society announced the selection of Prometheus Research as its principal informatics partner.
read more
Audax Private Equity has entered into a definitive agreement to acquire the Clinical Services business of Avantor, Inc. The deal is expected to close in the fourth quarter and is subject to regulatory approvals.
read more
Tuesday, September 04, 2018
Catalent Pharma Solutions announced a commercial supply agreement for Aucta Pharmaceuticals (Aucta) vigabatrin.
read more
ATUM and Phylex BioSciences have entered into a collaboration to leverage ATUM's Leap-In Transposase® platform to develop the cell line essential to the manufacturing of Phylex's universal SARS coronavirus vaccine candidate.
read more
ATUM (formerly DNA2.0) has announced an expansion of its services to include cell line development, which has been enabled by the company's proprietary Leap-In Transposase genome engineering tools. ATUM has also begun construction of a new, 7,000 SF...
read more
Today, ATS Labs, Inc. (ATS), majority owned by Ampersand Capital
Partners, announced that it acquired the assets of MicroTest Labs, Inc. (MTL) of Agawam, MA. The
acquisition of MTL is the first step in the strategy of ATS to expand its microbiology...
read more
Atrin Pharmaceuticals has announced receipt of a Phase 1 Small Business Technology Transfer (STTR) Award (R41CA203436) for approximately $300,000 from the National Cancer Institute (NCI) of the National Institutes of Health (NIH). The award supports ...
read more
Thursday, January 30, 2025
Atreo, Inc. has announced a strategic preferred partnership with N-SIDE. This collaboration aims to empower pharmaceutical and biotech companies with seamlessly integrated solutions, enabling faster drug development and improved operational ...
read more
Monday, September 25, 2017
Atox Bio today announced that it has been awarded the next option on a performance-based contract with the BARDA for the development of Reltecimod in patients with NSTI.
read more
Thursday, August 28, 2025
Atossa Therapeutics has selected PSI to operationalize and manage its planned (Z)-endoxifen monotherapy dose-ranging study in women with metastatic breast cancer (mBC). The study was designed following guidance from the FDA and is intended to ...
read more
Atossa Genetics Inc. has signed manufacturing and quality agreements with AAIPharma Services Corp./Cambridge Major Laboratories, Inc. for the manufacturing of a clinical supply for 4-Hydroxytamoxifen, the API in Atossa's leading drug candidate, ...
read more
Wednesday, September 02, 2020
Atorus Research has announced the release of their second R package, Tplyr.
read more